Sepsis Guidelines 2026 β 5 Key Changes Every Clinician Must Know | SSC 2026 Summary
π΄ The Surviving Sepsis Campaign (SSC) 2026 guidelines are here β and 5 things have fundamentally changed. This video is the series overview: a concise summary of every major update, whether you're a medical student, junior doctor, nurse, or ICU specialist. 129 recommendations | 46 entirely new topics | 69 expert panellists across 23 countries | 38% from LMIC settings | First full update since 2021. 00:00 Introduction β Why SSC 2026 Matters 02:04 GRADE Methodology β RECOMMEND vs SUGGEST 03:10 The 5 Changes at a Glance 04:37 Change 1 β qSOFA Out, NEWS & NEWS2 In 08:04 Change 2 β Fluids: Beyond the 30 mL/kg Rule 13:02 Change 3 β Beta-Lactam Prolonged Infusion 16:58 Change 4 β Vasopressors & Elderly MAP Target 20:29 Change 5 β De-escalation: Now a Strong Recommendation π THE 5 KEY CHANGES IN SSC 2026: 1οΈβ£ SCREENING β qSOFA is out. NEWS & NEWS2 are in (Strong Recommendation). qSOFA sensitivity ~51% vs NEWS sensitivity ~74% in ward-based cohorts. If your hospital uses NEWS2, you are already aligned. 2οΈβ£ FLUIDS β Beyond the 30 mL/kg rule. The 30 mL/kg bolus is RETAINED but reframed as Phase 1 of a new 4-phase model: Resuscitation β Reassessment β Post-resuscitation Strategy β Fluid Removal. Active fluid removal is entirely new. Albumin removed from resuscitation guidelines (ALBIOS trial). 3οΈβ£ ANTIMICROBIALS β Prolonged beta-lactam infusion upgraded from Suggest β Recommend (Strong). First bolus as standard, then prolonged infusion for subsequent doses. Applies to piperacillin-tazobactam, meropenem, ceftazidime, and cefepime. De-escalation also upgraded to Strong Recommendation. 4οΈβ£ VASOPRESSORS β Norepinephrine downgraded from Recommend β Suggest. Vasopressin and angiotensin II now valid first-line alternatives. NEW age-specific MAP target: 60β65 mmHg for patients aged β₯65 (65 Trial & OVATION-65: same mortality, significantly less AF). Hydrocortisone downgraded to Suggest (ADRENAL & APROCCHSS). 5οΈβ£ DE-ESCALATION β Upgraded to Strong Recommendation. Once cultures are available, narrow to the narrowest effective spectrum as soon as possible. Blood purification (haemoperfusion, high-dose CVVH, plasma exchange) now recommended AGAINST for all modalities β expanded from SSC 2021. π KEY EVIDENCE COVERED: SMART & SALT-ED trials β balanced crystalloids vs 0.9% saline (MAKE-30 endpoint) ALBIOS trial β albumin removed from sepsis resuscitation PLUS & BASICS trials β post-resuscitation fluid strategy ROSE framework (Vincent & De Backer) β fluid removal phase BLING III & 2024 meta-analysis β beta-lactam prolonged infusion, 30-day mortality benefit 65 Trial & OVATION-65 β MAP 60β65 mmHg in patients aged β₯65: same mortality, less AF ADRENAL & APROCCHSS β hydrocortisone downgraded to Suggest Clarification (Change 1): qSOFA was validated to predict poor outcomes β in-hospital mortality or prolonged ICU stay β in patients with suspected infection, and performs best outside the ICU (Seymour et al., JAMA 2016). It is retained for prognosis but deprecated as a single sepsis screening tool per SSC 2026. The ~51% vs ~74% sensitivity figures refer to sepsis identification/screening. π WHO IS THIS FOR? Medical students | Junior doctors | Nurses | ICU & critical care teams | MRCP / PACES candidates | Anyone managing sepsis or septic shock πΊ SSC 2026 SERIES β deep-dive episodes: Ep 1 β qSOFA vs NEWS2: The Evidence Ep 2 β Fluids in Sepsis 2026: The 4-Phase Model Ep 3 β Beta-Lactam Prolonged Infusion: The Pharmacology Ep 4 β Vasopressors & the Elderly MAP Target Ep 5 β De-escalation: Now Mandatory β οΈ TERMINOLOGY NOTE (~17:00): The term "inotropes" is used loosely when discussing noradrenaline. To be precise: noradrenaline (norepinephrine) is primarily a vasopressor (Ξ±1 β β SVR, β MAP) with a mild inotropic component (Ξ²1 β β HR, β contractility). In SSC 2026 the correct terminology is vasopressors. The clinical message is unchanged. π REFERENCE: Prescott HC et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026. Intensive Care Med. March 2026. π Subscribe to ClinicalMedEd for evidence-based medical education π Like if this helped | π¬ Questions in the comments #sepsis #sepsisguidelines2026 #ssc2026 #icu #septicshock #criticalcare #medicaleducation #MRCP #norepinephrine #NEWS2 #betlactam #antimicrobialresistance #sepsisnursing #internalmedicine #survivingsepsiscampaign #sepsistreatment #sepsisinfection #procalcitonin #vasopressors #prolongedinfusion

Sepsis 2026 - Ep 1: qSOFA vs NEWS2 Screening Guidelines | Surviving Sepsis Campaign

Hyponatremia Explained | Pathophysiology, SIADH & Classification | by an MRCP Examiner

The ABG Decision Guide Every Clinician Needs

Sepsis 2026 Fluid Resuscitation: What Really Changed | MRCP & USMLE

Antihypertensive Drugs

Living With A Pacemaker (common questions answered) - in Plain English!

SEPSISΒ Spectrum Explained: Sepsis-3, Septic Shock & MODS | by an MRCP Examiner

Deadly Iranian missiles strike US barracks, with Jon Elmer

Migraine Isn't Just A Headache: What To Test For. With Dr John Campbell

How to Read an ECG | Top 10 Steps Explained by an MRCP Examiner | ECG Interpretation Made Easy

Executive Committee Meeting - July 21, 2026

Chest X-ray Reading | Never Miss Urgent Findings with ABCDE

Pacemakers Explained: How They Work, Who Needs One & Whatβs New in 2025

USMLE Step 1, 2 & 3 Respiratory Diseases and Their Treatments Part 2

π©Ί All CNA Skills | Step-by-Step CNA Skills Review with Nurse Eunice (for ALL States)

Pneumonia: Part 1 | Clinical Medicine

Hyperkalemia Management: Stabilise, Shift & Remove | MRCP

The Complete Cardiology Masterclass: Exam-Ready in One Video

CFPS-ACE webinar: Osteoporosis (23 April 2026)

